Graphical Abstract - van Eijk and Steyn et al; Trimetazidine in amyotrophic lateral sclerosis (ALS)

eye open icon
View-only
chevron left icon
chevron right icon
chevron left icon
chevron right icon
No items found.

This figure is created in BioRender. Create your own professional science figure now!

Explore BioRender’s library of over 50,000 pre-made icons and templates from more than 30 fields of life sciences.
Try it now
Published figure
Link to publication coming soon
View in Biorender
chevron right icon

Description

No description has been provided for this figure.

Rationale, design and outcome measures for Targeting Metabolic Flexibility in ALS (MetFlex); Safety and Tolerability of Trimetazidine for the Treatment of ALS

Confirmation of the Author’s Publication and Licensing Rights

No confirmation has been provided for this figure.

How to cite this figure

text snippet icon
Copy in-text citation
Created in BioRender. Ngo, S. (2025) https://app.biorender.com/citation/679df2ec6a44123fa85434b8
text snippet icon
Copy bibliographic reference (APA Style)
Ngo, S. (2025). Graphical Abstract - van Eijk and Steyn et al; Trimetazidine in amyotrophic lateral sclerosis (ALS). Created in BioRender. https://app.biorender.com/citation/679df2ec6a44123fa85434b8

How to use this figure

Show More
Show Less